Operating Highlights
- Q3 2026 Sales increased
$43 million (14 percent) to$339 million compared to$296 million in Q3 2025. Q3 2026 organic sales increased$20 million (8 percent), and Maritime contributed$23 million of revenue growth in the quarter. - Q3 2026 GAAP EPS from Continuing Operations increased 31 percent to
$1.26 per share compared to$0.96 per share in Q3 2025. Q3 2026 Adjusted EPS from Continuing Operations increased 38 percent to$2.20 per share compared to$1.60 per share in Q3 2025. - Q3 2026 entered orders were
$410 million , with a book-to-bill ratio of 1.21. This resulted in record backlog atJune 30 of$1.54 billion . Q3 2026 orders were lower than the prior year due to$364 million of acquired backlog related to the acquisition of Maritime in Q3 2025. - Net cash provided by operating activities from Continuing Operations was
$193 million YTD, an increase of$105 million compared to the prior year period.
“Year to date, we have delivered double-digit organic sales growth across our aerospace,
Segment Performance
Aerospace & Defense (A&D)
- Q3 2026 sales increased
$31.9 million (23 percent) to$168.2 million from$136.3 million in Q3 2025. Organic sales increased$9.2 million (9 percent) and Maritime added$22.7 million of revenue growth in the quarter. Quarterly sales growth was led by strong performance in commercial aerospace andNavy . - Q3 2026 EBIT increased
$13.8 million to$50.4 million from$36.6 million in Q3 2025. Adjusted EBIT increased$11.2 million in Q3 2026 to$50.5 million (30.0 percent margin) from$39.3 million (28.8 percent margin) in Q3 2025. The 28 percent increase in Adjusted EBIT was driven by leverage on higher volume and price increases, partially offset by inflationary pressures and unfavorable mix. - Q3 2026 Entered Orders decreased
$386.7 million (66 percent) to$195.7 million , as Q3 2025 contained$364.2 million in acquired backlog related to the Maritime acquisition along with$67 million in Block V.2/VI Virginia Class and$15 million ofColumbia Class orders. Book-to-bill in the quarter was 1.16 driven by higher commercial and military aerospace OEM and aftermarket orders, resulting in record backlog of$1.1 billion .
- Q3 2026 sales increased
$7.6 million (8 percent) to$100.0 million from$92.4 million in Q3 2025. Doble sales increased by$12.9 million (17 percent) while NRG sales decreased by$5.3 million (29 percent). Sales growth in the quarter was driven by higher protection testing, offline test equipment, and services revenue at Doble, partially offset by lower renewables revenue at NRG. - Q3 2026 EBIT increased
$0.5 million to$22.0 million from$21.5 million in Q3 2025. Adjusted EBIT increased$0.5 million in Q3 2026 to$22.3 million (22.3 percent margin) from$21.8 million (23.6 percent margin) in Q3 2025. The increase in Adjusted EBIT was driven by leverage on higher volume at Doble and price increases, mostly offset by EBIT reductions at NRG due to lower sales volumes. - Q3 2026 entered orders increased
$21.4 million (20 percent) to$126.9 million (book-to-bill of 1.27), resulting in backlog of$189.4 million . Doble orders increased$26.4 million (30 percent) to$113.3 million as the business continues to experience broad based increases in demand from utility customers. NRG orders decreased$5.0 million (27 percent) to$13.5 million , related to the expiration ofU.S . renewables tax credits.
RF Test & Measurement (Test)
- Q3 2026 sales increased
$3.2 million (5 percent) to$70.9 million from$67.7 million in Q3 2025. Sales growth in the quarter was primarily driven by higherU.S Test & Measurement (EMC), and medical and industrial shielding. - Q3 2026 EBIT increased
$0.2 million to$10.9 million from$10.7 million in Q3 2025. Q3 2026 Adjusted EBIT increased$0.9 million to$11.6 million (16.4 percent margin) from$10.7 million (15.9 percent margin) in Q3 2025. The 8 percent increase in Adjusted EBIT was driven by leverage on higher volume and price increases, partially offset by inflationary pressures. - Q3 2026 entered orders increased
$25.8 million (42 percent) to$87.0 million (book-to-bill of 1.23), resulting in record backlog of$248.6 million . Orders strength in the quarter was driven by industrial shielding projects and electromagnetic interference (EMI) filters forU.S . data centers.
Megger Acquisition
As announced on
Business Outlook – FY 2026
FY 2026 Sales and Adjusted EPS Guidance Update:
- Raising the lower end of FY 2026 Sales guidance and now expect Sales to be in the range of
$1.30 to$1.33 billion (19 to 21 percent growth over the prior year). - Raising full year Adjusted EPS guidance to a range of
$8.30 -$8.40 per share (38 to 39 percent growth), which reflects a midpoint increase of$0.70 per share from our initial November guidance ($7.50 -$7.80 ) and$0.22 per share from our more recent May guidance update of ($8.00 -$8.25 ). - Q4’26 Adjusted EPS is expected to be in the range of
$2.55 -$2.65 per share (10 to 14 percent growth compared to Q4’25 Adjusted EPS).
Dividend Payment
The next quarterly cash dividend of
Conference Call
The Company will host a conference call today,
Forward-Looking Statements
Statements in this press release regarding Management’s intentions, expectations and guidance for fiscal 2026, including restructuring and cost reduction actions, sales, orders, revenues, margin, earnings, Adjusted EPS, acquisition related amortization, and any other statements which are not strictly historical, are “forward-looking statements” within the meaning of the safe harbor provisions of the
Investors are cautioned that such statements are only predictions and speak only as of the date of this release, and the Company undertakes no duty to update them except as may be required by applicable laws or regulations. The Company’s actual results in the future may differ materially from those projected in the forward-looking statements due to risks and uncertainties that exist in the Company’s operations and business environment including but not limited to those described in Item 1A, “Risk Factors”, of the Company’s Annual Report on Form 10-K for the fiscal year ended
Non-GAAP Financial Measures
The financial measures EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA, and Adjusted EPS are presented in this press release. The Company defines “EBIT” as earnings before interest and taxes, “EBITDA” as earnings before interest, taxes, depreciation and amortization, “Adjusted EBIT” and “Adjusted EBITDA” as excluding the net impact of the items described in the attached Reconciliation of Non-GAAP Financial Measures, and “Adjusted EPS” as GAAP earnings per share excluding the net impact of the items described and reconciled in the attached Reconciliation of Non-GAAP Financial Measures.
EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA, and Adjusted EPS are not recognized in accordance with
About ESCO
| Condensed Consolidated Statements of Operations (Unaudited) | |||||||||||
| (Dollars in thousands, except per share amounts) | |||||||||||
| Three Months Ended | Three Months Ended | ||||||||||
| $ | 339,027 | 296,344 | |||||||||
| Cost and Expenses: | |||||||||||
| Cost of sales | 197,508 | 174,350 | |||||||||
| Selling, general and administrative expenses | 71,002 | 62,042 | |||||||||
| Amortization of intangible assets | 20,342 | 16,753 | |||||||||
| Interest expense | 8,713 | 7,921 | |||||||||
| Other expenses (income), net | 508 | 2,209 | |||||||||
| Total costs and expenses | 298,073 | 263,275 | |||||||||
| Earnings before income taxes | 40,954 | 33,069 | |||||||||
| Income tax expense | 8,219 | 8,314 | |||||||||
| Earnings from continuing operations | 32,735 | 24,755 | |||||||||
| Earnings from discontinued operations, net of tax expense | |||||||||||
| of | - | 1,310 | |||||||||
| Net earnings | $ | 32,735 | 26,065 | ||||||||
| Diluted - GAAP | |||||||||||
| Continuing operations | $ | 1.26 | 0.96 | ||||||||
| Discontinued operations | 0.00 | 0.05 | |||||||||
| Net earnings | $ | 1.26 | 1.01 | ||||||||
| Diluted - As Adjusted Basis | |||||||||||
| Continuing Operations | $ | 2.20 | (1 | ) | 1.60 | (2 | ) | ||||
| Diluted average common shares | 25,980 | 25,918 | |||||||||
| (1 | ) | Q3 2026 Adjusted EPS from continuing operations excludes | |||||||||
| (2 | ) | Q3 2025 Adjusted EPS from continuing operations excludes | |||||||||
| Condensed Consolidated Statements of Operations (Unaudited) | |||||||||||
| (Dollars in thousands, except per share amounts) | |||||||||||
| Nine Months Ended | Nine Months Ended | ||||||||||
| $ | 938,027 | 742,714 | |||||||||
| Cost and Expenses: | |||||||||||
| Cost of sales | 545,274 | 431,068 | |||||||||
| Selling, general and administrative expenses | 195,039 | 171,305 | |||||||||
| Amortization of intangible assets | 61,086 | 32,735 | |||||||||
| Interest expense | 13,992 | 12,373 | |||||||||
| Other expenses (income), net | 2,340 | 1,947 | |||||||||
| Total costs and expenses | 817,731 | 649,428 | |||||||||
| Earnings before income taxes | 120,296 | 93,286 | |||||||||
| Income tax expense | 25,314 | 21,841 | |||||||||
| Earnings from continuing operations | 94,982 | 71,445 | |||||||||
| Earnings from discontinued operations, net of tax expense | |||||||||||
| of | 1,177 | 9,126 | |||||||||
| Net earnings | $ | 96,159 | 80,571 | ||||||||
| Diluted - GAAP | |||||||||||
| Continuing operations | $ | 3.66 | 2.76 | ||||||||
| Discontinued operations | 0.05 | 0.35 | |||||||||
| Net earnings | $ | 3.71 | 3.11 | ||||||||
| Diluted - As Adjusted Basis | |||||||||||
| Continuing Operations | $ | 5.75 | (1 | ) | 3.71 | (2 | ) | ||||
| Diluted average common shares | 25,932 | 25,876 | |||||||||
| (1 | ) | YTD Q3 2026 Adjusted EPS from continuing operations excludes | |||||||||
| (2 | ) | YTD Q3 2025 Adjusted EPS from continuing operations excludes | |||||||||
| Condensed Business Segment Information (Unaudited) - Continuing Operations basis | |||||||||||||||
| (Dollars in thousands) | |||||||||||||||
| GAAP | As Adjusted | ||||||||||||||
| Q3 2026 | Q3 2025 | Q3 2026 | Q3 2025 | ||||||||||||
| Aerospace & Defense | $ | 168,202 | 136,324 | 168,202 | 136,324 | ||||||||||
| USG | 99,963 | 92,357 | 99,963 | 92,357 | |||||||||||
| Test | 70,862 | 67,663 | 70,862 | 67,663 | |||||||||||
| Totals | $ | 339,027 | 296,344 | 339,027 | 296,344 | ||||||||||
| EBIT | |||||||||||||||
| Aerospace & Defense | $ | 50,418 | 36,577 | 50,455 | 39,319 | ||||||||||
| USG | 21,983 | 21,540 | 22,282 | 21,789 | |||||||||||
| Test | 10,882 | 10,732 | 11,617 | 10,732 | |||||||||||
| Corporate | (33,616 | ) | (27,859 | ) | (9,678 | ) | (9,184 | ) | |||||||
| Consolidated EBIT | 49,667 | 40,990 | 74,676 | 62,656 | |||||||||||
| Less: Interest expense | (8,713 | ) | (7,921 | ) | (1,850 | ) | (7,921 | ) | |||||||
| Less: Income tax expense | (8,219 | ) | (8,314 | ) | (15,548 | ) | (13,297 | ) | |||||||
| Net earnings | $ | 32,735 | 24,755 | 57,278 | 41,438 | ||||||||||
| Note 1: Adjusted net earnings of | |||||||||||||||
| Note 2: Adjusted net earnings of | |||||||||||||||
| EBITDA Reconciliation to Net earnings: | Q3 2026 - | Q3 2025 - | |||||||||||||
| Q3 2026 | Q3 2025 | As Adj | As Adj | ||||||||||||
| Consolidated EBITDA | $ | 76,410 | 63,350 | 83,755 | 71,545 | ||||||||||
| Less: Depr & Amort | (26,743 | ) | (22,360 | ) | (9,079 | ) | (8,889 | ) | |||||||
| Consolidated EBIT | 49,667 | 40,990 | 74,676 | 62,656 | |||||||||||
| Less: Interest expense | (8,713 | ) | (7,921 | ) | (1,850 | ) | (7,921 | ) | |||||||
| Less: Income tax expense | (8,219 | ) | (8,314 | ) | (15,548 | ) | (13,297 | ) | |||||||
| Net earnings | $ | 32,735 | 24,755 | 57,278 | 41,438 | ||||||||||
| Condensed Business Segment Information (Unaudited) - Continuing Operations basis | |||||||||||||||
| (Dollars in thousands) | |||||||||||||||
| GAAP | As Adjusted | ||||||||||||||
| YTD | YTD | YTD | YTD | ||||||||||||
| Q3 2026 | Q3 2025 | Q3 2026 | Q3 2025 | ||||||||||||
| Aerospace & Defense | $ | 462,341 | 307,819 | 462,341 | 307,819 | ||||||||||
| USG | 280,976 | 269,784 | 280,976 | 269,784 | |||||||||||
| Test | 194,710 | 165,111 | 194,710 | 165,111 | |||||||||||
| Totals | $ | 938,027 | 742,714 | 938,027 | 742,714 | ||||||||||
| EBIT | |||||||||||||||
| Aerospace & Defense | $ | 131,372 | 78,246 | 131,650 | 81,016 | ||||||||||
| USG | 63,998 | 62,808 | 64,929 | 63,140 | |||||||||||
| Test | 27,697 | 21,523 | 29,754 | 21,988 | |||||||||||
| Corporate | (88,779 | ) | (56,918 | ) | (28,322 | ) | (28,142 | ) | |||||||
| Consolidated EBIT | 134,288 | 105,659 | 198,011 | 138,002 | |||||||||||
| Less: Interest expense | (13,992 | ) | (12,373 | ) | (7,129 | ) | (12,373 | ) | |||||||
| Less: Income tax | (25,314 | ) | (21,841 | ) | (41,546 | ) | (29,279 | ) | |||||||
| Net earnings | $ | 94,982 | 71,445 | 149,336 | 96,350 | ||||||||||
| Note 1: Adjusted net earnings of | |||||||||||||||
| Note 2: Adjusted net earnings of | |||||||||||||||
| EBITDA Reconciliation to Net earnings: | YTD | YTD | |||||||||||||
| YTD | YTD | Q3 2026 - | Q3 2025 - | ||||||||||||
| Q3 2026 | Q3 2025 | As Adj | As Adj | ||||||||||||
| Consolidated EBITDA | $ | 214,361 | 154,060 | 225,182 | 162,975 | ||||||||||
| Less: Depr & Amort | (80,073 | ) | (48,401 | ) | (27,171 | ) | (24,973 | ) | |||||||
| Consolidated EBIT | 134,288 | 105,659 | 198,011 | 138,002 | |||||||||||
| Less: Interest expense | (13,992 | ) | (12,373 | ) | (7,129 | ) | (12,373 | ) | |||||||
| Less: Income tax expense | (25,314 | ) | (21,841 | ) | (41,546 | ) | (29,279 | ) | |||||||
| Net earnings | $ | 94,982 | 71,445 | 149,336 | 96,350 | ||||||||||
| Condensed Consolidated Balance Sheets (Unaudited) | ||||||
| (Dollars in thousands) | ||||||
2026 | 2025 | |||||
| Assets | ||||||
| Cash and cash equivalents | $ | 73,236 | 101,350 | |||
| Accounts receivable, net | 267,493 | 253,554 | ||||
| Contract assets | 127,620 | 90,730 | ||||
| Inventories | 240,542 | 217,807 | ||||
| Other current assets | 46,620 | 25,065 | ||||
| Total current assets | 755,511 | 688,506 | ||||
| Property, plant and equipment, net | 175,282 | 172,493 | ||||
| Intangible assets, net | 664,450 | 723,973 | ||||
| 760,275 | 761,931 | |||||
| Operating lease assets | 47,271 | 47,707 | ||||
| Other assets | 17,214 | 15,778 | ||||
| $ | 2,420,003 | 2,410,388 | ||||
| Liabilities and Shareholders' Equity | ||||||
| Current maturities of long-term debt | $ | 20,000 | 20,000 | |||
| Accounts payable | 116,539 | 96,534 | ||||
| Contract liabilities | 288,142 | 216,590 | ||||
| Current income tax payable | 5,754 | 62,007 | ||||
| Other current liabilities | 116,258 | 113,017 | ||||
| Total current liabilities | 546,693 | 508,148 | ||||
| Deferred tax liabilities | 115,333 | 112,390 | ||||
| Non-current operating lease liabilities | 44,107 | 44,403 | ||||
| Other liabilities | 31,608 | 38,576 | ||||
| Long-term debt | 65,000 | 166,000 | ||||
| Shareholders' equity | 1,617,262 | 1,540,871 | ||||
| $ | 2,420,003 | 2,410,388 | ||||
| Consolidated Statements of Cash Flows (Unaudited) | ||||||
| (Dollars in thousands) | ||||||
| Nine Months Ended | Nine Months Ended | |||||
| Cash flows from operating activities: | ||||||
| Net earnings | $ | 96,159 | 80,571 | |||
| (Earnings) loss from discontinued operations | (1,177 | ) | (9,126 | ) | ||
| Adjustments to reconcile net earnings to net cash | ||||||
| provided by operating activities: | ||||||
| Depreciation and amortization | 80,073 | 48,401 | ||||
| Stock compensation expense | 10,182 | 7,934 | ||||
| Changes in assets and liabilities | 2,983 | (33,473 | ) | |||
| Effect of deferred taxes | 5,157 | (6,008 | ) | |||
| Net cash provided by operating activities - continuing operations | 193,377 | 88,299 | ||||
| Net cash provided (used) by operating activities-discontinued ops | (59,340 | ) | 43,703 | |||
| Net cash provided by operating activities | 134,037 | 132,002 | ||||
| Cash flows from investing activities: | ||||||
| Acquisition of business, net of cash acquired | (10,232 | ) | (472,006 | ) | ||
| Capital expenditures | (24,560 | ) | (24,210 | ) | ||
| Additions to capitalized software and other | (7,874 | ) | (13,018 | ) | ||
| Net cash used by investing activities - continuing operations | (42,666 | ) | (509,234 | ) | ||
| Net cash provided (used) by investing activities - discontinued ops | 1,540 | (966 | ) | |||
| Net cash used by investing activities | (41,126 | ) | (510,200 | ) | ||
| Cash flows from financing activities: | ||||||
| Proceeds from long-term debt | 130,000 | 645,000 | ||||
| Principal payments on long-term debt and short-term borrowings | (231,000 | ) | (242,000 | ) | ||
| Debt issuance costs | (1,293 | ) | - | |||
| Dividends paid | (6,216 | ) | (6,196 | ) | ||
| Other | (10,646 | ) | (6,205 | ) | ||
| Net cash (used) provided by financing activities | (119,155 | ) | 390,599 | |||
| Effect of exchange rate changes on cash and cash equivalents | (1,870 | ) | 452 | |||
| Net (decrease) increase in cash and cash equivalents | (28,114 | ) | 12,853 | |||
| Cash and cash equivalents, beginning of period | 101,350 | 65,963 | ||||
| Cash and cash equivalents, end of period | $ | 73,236 | 78,816 | |||
| Other Selected Financial Data (Unaudited) | ||||||||||||||
| (Dollars in thousands) | ||||||||||||||
| Backlog And Entered Orders - Q3 2026 | A&D | USG | Test | Total | ||||||||||
| Beginning Backlog - | $ | 1,074,987 | 162,510 | 232,507 | 1,470,004 | |||||||||
| Entered Orders | 195,661 | 126,879 | 86,998 | 409,538 | ||||||||||
| Sales | (168,202 | ) | (99,963 | ) | (70,862 | ) | (339,027 | ) | ||||||
| Ending Backlog - | $ | 1,102,446 | 189,426 | 248,643 | 1,540,515 | |||||||||
| Backlog And Entered Orders - YTD Q3 2026 | A&D | USG | Test | Total | ||||||||||
| Beginning Backlog - | $ | 803,002 | 143,460 | 187,175 | 1,133,637 | |||||||||
| Entered Orders | 761,785 | 326,942 | 256,178 | 1,344,905 | ||||||||||
| Sales | (462,341 | ) | (280,976 | ) | (194,710 | ) | (938,027 | ) | ||||||
| Ending Backlog - | $ | 1,102,446 | 189,426 | 248,643 | 1,540,515 | |||||||||
| Reconciliation of Non-GAAP Financial Measures (Unaudited) | |||
| EPS – Adjusted Basis Reconciliation – Q3 2026 | |||
| EPS Continuing Operations– GAAP Basis – Q3 2026 | $ | 1.26 | |
| Adjustments (defined below) | 0.94 | ||
| EPS Continuing Operations– As Adjusted Basis – Q3 2026 | $ | 2.20 | |
| Adjustments of | |||
| segment restructuring charges, | |||
| costs at Corporate related to the pending Megger acquisition, and | |||
| acquisition related amortization. | |||
| EPS – Adjusted Basis Reconciliation – Q3 2025 | |||
| EPS Continuing Operations– GAAP Basis – Q3 2025 | $ | 0.96 | |
| Adjustments (defined below) | 0.64 | ||
| EPS Continuing Operations– As Adjusted Basis – Q3 2025 | $ | 1.60 | |
| Adjustments of | |||
| acquisition costs, | |||
| related amortization. | |||
| EPS – Adjusted Basis Reconciliation – YTD Q3 2026 | |||
| EPS Continuing Operations– GAAP Basis – YTD Q3 2026 | $ | 3.66 | |
| Adjustments (defined below) | 2.09 | ||
| EPS Continuing Operations – As Adjusted Basis – YTD Q3 2026 | $ | 5.75 | |
| Adjustments of | |||
| charges within Test, USG and A&D segments, | |||
| acquisition costs related to the pending Megger acquisition, and | |||
| related amortization. | |||
| EPS – Adjusted Basis Reconciliation – YTD Q3 2025 | |||
| EPS Continuing Operations– GAAP Basis – YTD Q3 2025 | $ | 2.76 | |
| Adjustments (defined below) | 0.95 | ||
| EPS Continuing Operations – As Adjusted Basis – YTD Q3 2025 | $ | 3.71 | |
| Adjustments of | |||
| acquisition costs, | |||
| acquisition related amortization. | |||
SOURCE
Source: